studi
propos
novel
bacteri
vaccin
strategi
nonpathogen
bacteria
complement
trait
desir
induct
protect
immun
illustr
proof
principl
novel
vaccin
strategi
use
model
organ
intracellular
immun
listeria
introduc
low
copi
number
bacplasmid
harbour
virul
gene
cluster
vgc
l
monocytogen
lm
nonpathogen
l
innocua
linn
strain
examin
abil
induc
protect
cellular
immun
result
strain
linn
vgc
attenu
virul
vivo
show
strongli
reduc
host
detriment
inflammatori
respons
compar
lm
like
lm
linn
vgc
induc
product
type
interferon
protect
mediat
listeriaspecif
cell
ration
vaccin
design
wherebi
avirul
strain
equip
capabl
induc
protect
lack
detriment
inflammatori
effect
offer
great
promis
toward
futur
studi
use
nonpathogen
bacteria
vector
vaccin
citat
moham
w
sethi
tchatalbachev
darji
chakraborti
protect
immun
listeria
monocytogen
infect
mediat
recombin
listeria
innocua
harbor
vgc
locu
plo
one
current
state
art
vaccin
technolog
focus
three
distinct
strategi
creation
live
attenu
pathogen
base
delet
virul
factor
use
subunit
vaccin
contain
one
semipur
antigen
critic
induc
immun
respons
use
metabol
activ
nonviabl
bacteria
first
strategi
must
consid
today
medicin
vaccin
often
administ
immunocompromis
individu
use
live
vaccin
subpopul
pose
seriou
difficulti
greatest
disadvantag
subunit
vaccin
gener
requir
strong
adjuv
adjuv
often
induc
detriment
tissu
reaction
lastli
concept
socal
kill
metabol
activ
kbma
bacteria
involv
bacteria
unabl
form
coloni
growth
media
still
intact
protein
synthesi
secret
machineri
mutant
reportedli
capabl
induc
cell
respons
protect
howev
requir
multipl
inject
lm
facult
intracellular
microorgan
mani
bacteri
determin
necessari
pathogenesi
includ
intracellular
growth
spread
lm
identifi
cluster
region
chromosom
term
virul
gene
cluster
vgc
encod
prfa
plca
hli
mpl
acta
plcb
gene
organ
three
transcript
unit
facult
intracellular
bacterium
make
lm
particularli
attract
potenti
live
vaccin
vector
induct
cellmedi
immun
foreign
antigen
howev
despit
capabl
induc
effect
tcell
respons
safeti
recombin
lm
remain
import
issu
infect
lm
caus
sever
lifethreaten
infect
moreov
infect
lm
mainli
accompani
undesir
tcell
mediat
delay
type
hypersensit
dth
respons
granulomat
inflamm
therefor
use
lm
clinic
set
associ
major
risk
limit
potenti
effect
vaccin
vector
altern
strategi
would
entail
transfer
core
set
virul
gene
pathogen
lm
creat
strain
attenu
virul
capabl
induc
effect
immun
respons
explor
approach
transfer
vgc
locu
lm
nonpathogen
speci
listeria
l
innocua
linn
carrier
strain
show
singl
immun
recombin
strain
linn
vgc
fulfil
desir
requir
success
bacteri
vaccin
vector
includ
low
virul
associ
induct
protect
antigenspecif
tcell
respons
reduct
cellmedi
inflamm
vivo
surviv
recombin
linn
vgc
strain
abil
listeria
surviv
vivo
earli
stage
infect
crucial
induct
cellmedi
immun
examin
abil
linn
vgc
surviv
spleen
liver
infect
mice
compar
wild
type
lm
balbc
mice
infect
intraven
iv
subleth
dose
wild
type
lm
egd
linn
vgc
wild
type
linn
strain
time
point
correl
critic
phase
host
immun
respons
listeri
infect
select
use
compar
bacteri
growth
induct
immun
effector
wildtyp
lm
linn
linn
vgc
strain
day
listeria
infect
refer
end
preimmun
phase
expans
specif
cell
mous
model
listeriosi
presenc
viabl
bacteria
day
shown
critic
success
induct
cellmedi
immun
therefor
day
bacteri
load
well
spleen
morpholog
analyz
day
correspond
primari
immun
effector
phase
time
point
dth
solubl
antigen
measur
vivo
indic
dth
reaction
cell
activ
moreov
number
antigen
specif
ifnc
produc
cytotox
cell
analyz
day
postinfect
well
day
postchalleng
chosen
analyz
memori
immun
effector
phase
end
number
memori
effector
tcell
determin
quantit
vivo
surviv
growth
kinet
bacteria
follow
determin
number
bacteria
spleen
liver
infect
mice
expect
regardless
dose
infect
wild
type
linn
strain
progress
clear
organ
fig
wherea
linn
vgc
strain
success
surviv
spleen
liver
first
two
day
infect
indic
bacteri
number
increas
spleen
liver
till
day
gradual
decreas
day
postinfect
hand
bacteri
number
wild
type
lm
increas
day
till
day
postinfect
spleen
liver
stimul
type
interferon
linn
vgc
strain
strike
phenomenon
cytosol
resid
microb
abil
induc
express
type
interferon
contrast
wild
type
lm
isogen
mutant
lack
listeriolysin
remain
trap
vacuol
induc
type
interferon
recent
document
linn
vgc
success
surviv
insid
phagocyt
cell
therebi
egress
phagolysosom
order
confirm
cytosol
persist
recombin
linn
vgc
strain
effici
enough
stimul
product
cytokin
examin
transcript
respons
bone
marrowderiv
macrophag
follow
infect
lm
linn
well
recombin
linn
vgc
strain
linn
vgc
wild
type
lm
show
significantli
higher
transcript
induct
wild
type
linn
hour
postinfect
fig
effect
pronounc
later
time
point
hour
postinfect
reflect
effici
intracellular
surviv
pattern
linn
vgc
strain
recombin
linn
vgc
strain
exhibit
lower
inflammatori
respons
earli
stage
infect
wild
type
lm
engulf
profession
phagocyt
like
macrophag
dendrit
cell
neutrophil
cell
produc
varieti
proinflammatori
cytokin
recruit
activ
inflammatori
immun
cell
level
tnfalpha
mice
sera
measur
first
day
infect
lm
linn
linn
vgc
strain
like
l
inn
linn
vgc
abl
produc
signific
amount
cytokin
first
day
postinfect
spite
high
infect
dose
primari
infect
lm
led
high
proinflammatori
cytokin
product
fig
granuloma
format
delayedtypehypersensit
footpad
respons
previous
shown
cell
depend
inflammatori
respons
follow
infect
lm
morpholog
chang
examin
spleen
day
iv
infect
although
number
bacteria
spleen
day
postinfect
lm
linn
vgc
approxim
fig
distinct
differ
morpholog
appear
spleen
isol
mice
infect
lm
isol
mice
infect
linn
vgc
observ
fig
splenomegali
associ
extens
granuloma
format
observ
spleen
lm
infect
mice
result
intens
leukocyt
infiltr
visual
stain
spleen
section
fig
wherea
splenomegali
absenc
granuloma
format
observ
spleen
linn
vgc
infect
mice
infect
wild
type
linn
result
morpholog
chang
spleen
observ
confirm
antigenelicit
skin
respons
show
correspond
result
fig
mice
inject
left
hind
footpad
ml
somat
solubl
lm
egd
antigen
ngml
day
postinfect
twentyfour
hour
later
thick
left
right
footpad
individu
mice
measur
footpad
mice
preimmun
linn
vgc
show
reduc
thick
mice
preimmun
wild
type
lm
wild
type
linn
strain
induc
dth
respons
footpad
mice
moreov
antigeninduc
cellderiv
ifngamma
product
spleen
cell
measur
indic
proinflammatori
cell
respons
spleen
cell
isol
day
postinfect
stimul
vitro
releas
solubl
antigen
l
monocytogen
egd
ng
spleen
cell
mice
immun
linn
vgc
produc
significantli
lower
level
ifngamma
compar
spleen
cell
mice
immun
wild
type
lm
wild
type
linn
strain
fail
prime
cell
product
ifngamma
fig
supplementari
inform
induct
cellmedi
immun
recombin
linn
vgc
strain
number
cell
type
involv
host
defens
listeria
antigenspecif
lymphocyt
mediat
recoveri
primari
listeri
infect
protect
immun
subsequ
infect
helper
mhc
class
ii
restrict
cytotox
mhc
class
restrict
cell
subpopul
implic
experiment
evid
indic
howev
cell
play
predomin
role
mediat
protect
immun
abil
recombin
linn
vgc
induc
tcell
mediat
immun
prerequisit
protect
immun
analyz
group
balbc
mice
infect
lm
linn
linn
vgc
two
month
later
mice
challeng
lethal
iv
dose
correspond
wild
type
lm
surviv
monitor
control
group
untreat
balbc
mice
receiv
similar
lethal
dose
wild
type
lm
includ
singl
preimmun
linn
vgc
strain
led
signific
protect
subsequ
lethal
infect
lm
expect
mice
preimmun
subleth
dose
lm
also
protect
lethal
listeri
infect
surviv
wherea
nonimmun
mice
well
preimmun
linn
die
within
day
challeng
fig
entri
listeria
cytosol
critic
event
cell
recognit
induct
immun
order
establish
correl
protect
mice
preinfect
lm
linn
vgc
strain
upon
lethal
challeng
induct
cell
respons
infect
gener
antigenspecif
mhc
class
restrict
cell
quantit
examin
number
antigenspecif
mhc
class
restrict
effector
cell
induc
mice
spleen
day
primari
infect
day
challeng
wild
type
lm
determin
evalu
number
ifnc
produc
cell
induc
show
reactiv
domin
restrict
llo
epitop
vitro
elispot
assay
shown
fig
infect
wild
type
lm
well
linn
vgc
strain
induc
signific
number
llo
specif
tcell
recal
infect
number
llo
specif
tcell
show
signific
increas
hand
infect
linn
fail
induc
signific
number
tcell
either
primari
infect
challeng
address
contribut
effector
memori
cell
mediat
longlast
immun
reinfect
wild
type
lm
express
level
cell
surfac
adhes
molecul
quantifi
express
regul
surfac
cytotox
tcell
develop
protect
memori
cell
two
month
primari
infect
number
lo
lymphocyt
approxim
ident
group
primarili
infect
mice
number
increas
dramat
upon
reinfect
wild
type
lm
mice
preimmun
lm
well
linn
vgc
preimmun
linn
abl
induc
downregul
seen
group
fig
addit
monitor
express
tcell
express
high
level
memori
tcell
mice
primarili
infect
lm
linn
vgc
express
upregul
tcell
day
postchalleng
infect
wild
type
lm
primari
infect
linn
lead
signific
chang
express
pattern
fig
studi
defin
uniqu
vaccin
strategi
base
ration
design
pathogen
complement
non
pathogen
strain
select
gene
necessari
induc
vigor
immun
respons
illustr
proof
principl
strategi
use
listeria
model
take
nonpathogen
linn
strain
complement
gene
pathogen
lm
previous
shown
sine
qua
non
requir
intracellular
growth
surviv
novel
vaccin
strategi
result
gener
recombin
strain
linn
vgc
possess
properti
need
induc
mark
protect
immunogen
properti
wild
type
lm
attenu
virul
well
capac
induc
host
detriment
cellmedi
inflamm
recombin
linn
vgc
strain
show
signific
vivo
surviv
rate
first
day
postinfect
fig
observ
accord
recent
find
linn
vgc
strain
abl
surviv
phagocyt
host
cell
moreov
capabl
induc
ident
type
interferon
level
similar
wild
type
lm
previous
shown
mcaffrey
et
al
induct
type
ifn
surrog
marker
indic
access
listeria
cytosol
antigen
present
cell
shown
linn
vgc
strain
could
use
complement
virul
factor
escap
cytosol
subsequ
present
lymphocyt
context
zwaferink
et
al
shown
role
ifnb
macrophag
cell
death
treatment
macrophag
cytokin
could
enhanc
hostcel
membran
permeabil
listeriolysin
consequ
lead
cell
apoptosi
especi
encourag
observ
although
linn
vgc
strain
inject
high
dose
cfu
mice
could
still
effici
control
infect
show
low
blood
level
proinflammatori
cytokin
thu
reduc
detriment
inflammatori
respons
caus
wild
type
lm
morpholog
histolog
analysi
spleen
infect
lm
shown
induct
splenomegali
granuloma
result
monocyt
infiltr
white
pulp
pronounc
day
postinfect
infect
linn
vgc
result
splenomegali
without
signific
morpholog
chang
detect
fig
intens
morpholog
histolog
alter
spleen
parallel
level
listeriainduc
dth
respons
vivo
induct
dth
linn
vgc
infect
also
significantli
lower
dth
induct
follow
lm
infect
fig
fig
therefor
show
recombin
linn
vgc
strain
show
significantli
reduc
proinflammatori
mediat
inflammatori
respons
compar
lm
therebi
address
one
major
concern
regard
use
live
lm
vaccin
howev
crucial
question
remain
whether
linn
vgc
strain
elicit
signific
adapt
immun
respons
resembl
wildtyp
strain
sinc
lm
locat
phagosom
cytosol
profession
antigenpres
cell
infect
epitop
deriv
listeria
protein
present
mhc
pathway
therebi
prime
effector
cell
result
full
elimin
listeria
host
previou
experiment
studi
reveal
persist
number
viabl
microorgan
import
paramet
establish
effici
cellmedi
immun
moreov
shown
presenc
live
bacteria
mice
organ
first
hour
immun
critic
induct
effector
cell
mechan
inde
abl
show
anim
immun
lm
linn
vgc
protect
virul
listeria
fig
although
linn
vgc
strain
elicit
lower
mediat
inflammatori
respons
compar
infect
lm
capabl
mount
success
antilisteri
protect
respons
indic
observ
vivo
surviv
pattern
linn
vgc
strain
suffici
induc
protect
entri
effector
cell
memori
stage
howev
accompani
abil
rapidli
expand
popul
recal
respons
regul
express
cell
surfac
marker
previous
report
primari
infect
wild
type
lm
induc
regul
surfac
effector
cell
reach
lowest
level
day
postinfect
howev
follow
week
express
regul
recal
infect
rapidli
regul
surfac
memori
cell
order
correl
protect
challeng
listeria
antigen
specif
cell
examin
induct
llo
specif
cell
respons
primari
infect
differ
listeria
strain
infect
linn
vgc
induc
signific
popul
cytotox
lymphocyt
fig
upon
challeng
wild
type
lm
show
express
pattern
similar
present
mice
primarili
infect
wild
type
lm
fig
ident
memori
tcell
induc
respons
linn
vgc
infect
confirm
test
express
tcell
follow
recal
infect
lm
high
express
observ
tcell
deriv
mice
primarili
infect
recombin
linn
vgc
strain
wild
type
linn
fig
inabl
lm
strain
lack
listeriolysin
llo
well
linn
strain
express
llo
induc
protect
cell
respons
reflect
requir
entir
virul
gene
cluster
confer
long
last
immun
therefor
show
nonpathogen
linn
strain
complement
entir
vgc
capabl
induc
vigor
antilisteri
respons
even
though
demonstr
vigor
immun
respons
follow
iv
infect
immun
respons
listeria
vari
consider
depend
rout
administr
use
intraperiton
rout
infect
obtain
similar
result
ie
protect
follow
preinfect
lm
l
inn
vgc
strain
mice
preimmun
l
inn
strain
fig
thu
despit
differ
rout
infect
lm
vgc
abl
induc
protect
invivo
mous
suitabl
reproduc
model
evalu
oral
immun
protocol
specif
listeri
inla
molecul
therefor
experi
examin
mucos
immun
carri
guinea
pig
model
listeri
infect
recent
highli
attenu
mutant
lm
develop
candid
vaccin
vector
howev
singl
immun
strain
suffici
induct
protect
cellular
immun
transcompl
strain
nonpathogen
l
inn
strain
express
gene
vgc
cluster
provid
robust
protect
singl
dose
cfu
bacteria
without
caus
sign
overt
ill
wild
type
lm
around
cfu
shown
figur
linn
vgc
strain
grow
invivo
beyond
day
postinfect
subsequ
elimin
properti
impart
protect
respons
rapid
elimin
host
consid
desir
properti
success
vaccin
vector
result
name
vivo
surviv
pattern
induct
interferon
antigen
specif
cell
lack
overt
detriment
inflammatori
reaction
importantli
induct
protect
challeng
listeria
allow
conclus
linn
vgc
strain
potenti
capabl
induc
protect
develop
strain
suitabl
live
bacteri
vaccin
vector
clinic
set
warrant
mice
experi
done
accord
requir
justusliebig
univers
giessen
anim
ethic
committe
ethic
approv
number
anim
sacrif
use
asphyxi
appropri
organ
asept
harvest
six
eight
weekold
femal
balbc
mice
purchas
harlan
winkelmann
borchen
germani
kept
breed
facil
specificpathogenfre
condit
use
experi
bacteri
strain
use
studi
wild
type
listeria
monocytogen
egd
serotyp
lm
wild
type
l
innocua
strain
serotyp
nctc
transform
either
recent
character
gramvegramv
shuttl
vector
refer
linn
vgc
strain
puvbbac
vector
without
insert
vgc
refer
linn
bacteria
grown
brainheart
infus
bhi
difco
augsburg
germani
broth
presenc
absenc
mgml
erythromycin
experi
erythromycin
use
select
antibiot
growth
linn
vgc
wild
type
linn
harbour
puvbbac
vector
wild
type
l
monocytogen
grown
absenc
erythromycin
experi
fresh
cultur
bacteria
prepar
overnight
cultur
use
briefli
bacteria
grown
brain
heart
infus
bhi
harvest
exponenti
growth
phase
wash
twice
pb
pellet
resuspend
pb
bacteri
concentr
calibr
optic
absorpt
dilut
prepar
pb
obtain
requir
number
bacteria
infect
protocol
anim
handl
previous
approv
institut
anim
ethic
committe
protocol
number
bone
marrowderiv
macrophag
isol
week
old
femal
mice
grown
differenti
day
condit
medium
approxim
concentr
cellswel
plate
day
infect
medium
exchang
mdem
medium
fc
cell
infect
cfu
per
well
wild
type
lm
linn
strain
well
recombin
linn
vgc
strain
h
h
cell
lyse
total
rna
isol
everi
bacteri
strain
neg
control
cell
least
two
well
six
well
tissu
cultur
plaqu
lyse
total
rna
isol
prior
lysi
cultur
medium
aspir
cell
lyse
use
rlt
lysi
buffer
qiagen
germani
total
rna
isol
use
rneasi
mini
kit
rnase
free
dnase
set
qiagen
follow
manufactur
protocol
rna
recov
rnase
free
water
heat
denatur
min
quantifi
nanodroph
uvvi
spectrophotomet
nanodrop
technolog
usa
qualiti
profil
agil
bioanalyz
agil
technolog
germani
made
firststrand
cdna
synthes
ng
purifi
rna
use
superscriptii
invitrogen
mixtur
random
nonam
primer
metabion
follow
instruct
revers
transcript
reaction
recommend
quantitect
sybr
green
pcr
kit
qiagen
realtim
quantit
pcr
perform
abi
prism
real
time
cycler
rel
express
target
interferon
alpha
interferon
beta
normal
two
refer
gene
sdha
succin
dehydrogenas
alpha
subunit
ppia
peptidylprolyl
isomeras
final
mean
fold
chang
target
versu
refer
gene
taken
final
valu
somat
solubl
antigen
prepar
cultur
lm
tryptic
soy
broth
h
wash
pb
subsequ
subject
g
wet
weight
bacteri
cell
suspend
ml
pb
sonic
five
time
min
output
degre
sonifi
model
branson
sonic
power
usa
ice
sonic
suspens
centrifug
u
min
supernat
filter
steril
pore
mm
store
dilut
pb
primari
vivo
infect
lm
wild
type
linn
linn
vgc
strain
perform
intraven
inject
viabl
bacteria
volum
ml
pb
bacteri
growth
spleen
liver
determin
plate
serial
dilut
organ
homogen
bhi
agar
plate
detect
limit
procedur
coloni
form
unit
cfu
per
organ
coloni
count
h
incub
cytokin
product
assay
collect
sera
infect
mice
use
multiplex
cytokin
assay
kit
luminex
technolog
biorad
balbc
mice
infect
lm
wild
type
linn
linn
vgc
strain
sera
asept
isol
day
postinfect
four
cytokin
test
tnfa
cytokin
level
present
absolut
concentr
pg
ml
spleen
asept
isol
mice
previous
infect
differ
listeria
strain
mention
examin
morpholog
alter
tissu
fix
neutral
buffer
formalin
embed
paraffin
section
mm
section
stain
hematoxylin
eosin
pathoplog
foci
spleen
section
microscop
examin
keyenc
spleen
asept
remov
mice
day
postinfect
wild
type
lm
wild
type
linn
linn
vgc
strain
spleen
cell
isol
antigen
llo
specif
ifnc
produc
cell
determin
spleen
mice
iv
infect
bacteri
strain
mention
use
elispot
system
previous
describ
quantif
ifngamma
cell
cultur
supernat
ifngamma
measur
supernat
splenocyt
use
mous
ifngamma
elisa
kit
bd
opteia
tm
bd
bioscienc
pharmigen
accord
manufactur
instruct
assay
perform
duplic
data
repres
mean
standard
error
flow
cytometri
analysi
approxim
splenocyt
isol
infect
mice
lm
linn
linn
vgc
strain
stain
fitc
label
biotinyl
pharmingen
becton
dickinson
peconjug
streptavidin
use
detect
bind
cell
surfac
flow
cytometri
perform
use
fac
calibur
flow
cytomet
analyz
cell
quest
softwar
becton
dickinson
ca
mice
preimmun
wild
type
lm
wild
type
linn
strain
linn
vgc
strain
challeng
month
later
lethal
dose
wild
type
lm
group
non
preimmun
balbc
mice
includ
control
surviv
mice
monitor
sever
day
express
percentag
anim
surviv
challeng
lm
data
repres
least
three
independ
experi
signific
repres
data
calcul
use
anova
analysi
varianc
data
express
mean
standard
error
se
figur
listeriainduc
ifngamma
product
spleen
cell
day
infect
iv
mice
infect
cfu
lm
cfu
wild
type
linn
cfu
linn
vgc
strain
day
infect
mice
kill
spleen
remov
singl
cell
suspens
stimul
vitro
secret
solubl
listeria
antigen
produc
ifngamma
hour
cultur
supernat
test
presenc
ifngamma
elisa
egd
vs
linn
vgc
tif
figur
intraperiton
infect
linn
vgc
strain
induc
protect
immun
mice
infect
intraperiton
lm
linn
linn
vgc
strain
describ
figur
month
mice
challeng
iv
lethal
dose
wild
type
lm
control
group
uninfect
normal
mice
includ
surviv
monitor
day
challeng
tif
figur
quantif
express
splenocyt
follow
primari
recal
infect
lm
linn
linn
vgc
strain
flow
cytometri
perform
spleen
cell
isol
mice
day
primari
infect
day
challeng
cell
stain
fitclabel
pelabel
number
shown
gate
hi
cell
analyz
cellquest
softwar
tif
